Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Mar. 31, 2019
Current assets:        
Cash and cash equivalents $ 4,551 $ 3,691 $ 4,284 $ 3,689
Accounts receivable, net 4,774 4,062    
Inventories, net 4,193 2,192    
Prepaid expenses and other current assets 2,814 2,256    
Current portion of deferred consideration, net of discount 188 182    
Total current assets 16,520 12,383    
Operating lease right-of-use assets 343 963    
Property and equipment, net 372 365    
Deferred consideration, net of discount, less current portion 779 786    
Other assets 69 64    
Total assets 18,083 14,561    
Current liabilities:        
Accounts payable 4,133 2,086    
Accrued expenses and other current liabilities 918 1,774    
Deferred revenue 150 228    
Deferred revenue Invekra 46 45    
Operating lease liabilities 135 251    
Current portion of long-term debt 265 481    
Total current liabilities 5,647 4,865    
Operating lease liabilities - non-current 221 746    
Long-term deferred revenue Invekra 240 245    
Long-term debt 1,310 0    
Total liabilities 7,418 5,856    
Commitments and Contingencies (Note 7)    
Stockholders' Equity        
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at June 30, 2020 and March 31, 2020, respectively, 0 and 1.55 shares issued and outstanding at June 30, 2020 and March 31, 2020, respectively 0 0    
Common stock, $0.0001 par value; 24,000,000 shares authorized at June 30, 2020 and March 31, 2020, 1,966,958 and 1,777,483 shares issued and outstanding at June 30, 2020 and March 31, 2020, respectively 2 2    
Additional paid-in capital 188,112 186,559    
Accumulated deficit (172,006) (172,246)    
Accumulated other comprehensive loss (5,443) (5,610)    
Total stockholders' equity 10,665 8,705 $ 11,504 $ 10,489
Total liabilities and stockholders' equity $ 18,083 $ 14,561